Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
- Citation:
- J Clin Oncol vol 24 (9) 1395-403
- Year:
- 2006
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA03927, CA04326, CA07968, CA12046, CA12449, CA16450, CA21060, CA23318, CA27525, CA31946, CA32291, CA33601, CA60138, CA77651
- Corr. Author:
- Nancy E Kemeny
- Authors:
- Nancy E Kemeny Donna Niedzwiecki Donna R Hollis Heinz-Josef Lenz Robert S Warren Michelle J Naughton Jane C Weeks Elin R Sigurdson James E Herndon Chunfeng Zhang Robert J Mayer
- Networks:
- Study
- CALGB-9481
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Colorectal Neoplasms, Disease Progression, Female, Fluorouracil, Hepatic Artery, Humans, Infusions, Intra-Arterial, Injections, Intravenous, Leucovorin, Liver Neoplasms, Male, Middle Aged, Quality of Life, Survival Analysis, Treatment Outcome